rovalpituzumab tesirine April 12, 2017 rovalpituzumab tesirine Trade Name Orphan Indication Small cell lung cancer USA Market Approval USA USA Designation Date 2015-12-22 00:00:00 Sponsor AbbVie Inc.;Dept. PA77, Bldg. AP30-1, 1 Waukegan Road;Lake Bluff, Illinois, 60044
